Samsung Biologics to launch an all-cash public tender offer for 100% of PolyPeptide's fully diluted share capital (excluding therefrom any treasury shares) at CHF 44.31 per share, representing an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results